INS and type 2 diabetes mellitus: IR is defined as the decreased sensitivity to metabolic actions of insulin, and it occurs early in the natural history of T2D and during RA; HOmeostasis Model Assessment of Insulin Resistance (HOMA-IR) is considered the most reliable and cost-effective surrogate measure in clinical settings.